WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-20·Latest →

Altria (MO) Stock Analysis

OW

MO Equity Research — OVERWEIGHT — July 2026

← MDLZPEP →

Rating date

Jul 20, 2026

21 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

95p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · MO

Below is the equity analysis for MO (Altria Group) as of 20 July 2026.

Desk rating

OW

Tactical OW · 12M OW

Horizon

Short to medium term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • Trend remains bullish: MO is in a well-defined uptrend with price above both the 50- and 200-day SMAs, and the gap between them is widening.
  • Recent momentum softened but is recovering: RSI dipped below 50 in mid-July but has recovered to ~62; MACD is positive and appears to be turning higher after a multi-week decline. The recovery needs follow-through.
  • Price is near the upper Bollinger Band: At $74.21 vs. a $75.00 upper band, MO is modestly extended. A break above $75.00 on strong volume would be bullish; a rejection could trigger a pullback toward the middle band (~$72.30).

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

MO Research Note

Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

29 min read

WebserviceX · Agentic Research Desk

MO Equity Research Note

Published Jul 20, 2026 · Desk view OVERWEIGHT · Generated 2026-07-21T15:43:02Z · Maintained by Walter Vijayakumar · Methodology · Track record

MO Stock Rating Summary

MO bias

OVERWEIGHT

Horizon

Short to medium term

MO key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

MO catalyst watch

Trend remains bullish: MO is in a well-defined uptrend with price above both the 50- and 200-day SMAs, and the gap between them is widening.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 95p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:30.697706+00:00.

5D move

—

2026-07-20 → awaiting

Outcome

Awaiting market data

5D trend

+3.88%

Vol (20D ann.)

+24.86%

vs SPY: +4.83%

Close 74.66 → — (USD, vendor closes)

Batch scorecard · 2026-07-20 · MO

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace f9aeb414…

No QC issues recorded.